Karin M. Knudson

1.1k total citations
24 papers, 807 citations indexed

About

Karin M. Knudson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Karin M. Knudson has authored 24 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 17 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Karin M. Knudson's work include Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (10 papers) and Immune Cell Function and Interaction (10 papers). Karin M. Knudson is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (10 papers) and Immune Cell Function and Interaction (10 papers). Karin M. Knudson collaborates with scholars based in United States, United Kingdom and China. Karin M. Knudson's co-authors include Sofia R. Gameiro, Jeffrey Schlom, Kristin C. Hicks, Emma Teixeiro, Mark A. Daniëls, Xiaoling Luo, Jin‐Qiu Chen, James W. Hodge, Sarah Alter and Anthony S. Malamas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Immunology.

In The Last Decade

Karin M. Knudson

23 papers receiving 798 citations

Peers

Karin M. Knudson
Benjamin Cottam United States
Jens Pahl Germany
Anthony Miliotto United States
Xuexiang Du United States
Kellsye P. Fabian United States
Judy Browning Australia
Benjamin Cottam United States
Karin M. Knudson
Citations per year, relative to Karin M. Knudson Karin M. Knudson (= 1×) peers Benjamin Cottam

Countries citing papers authored by Karin M. Knudson

Since Specialization
Citations

This map shows the geographic impact of Karin M. Knudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin M. Knudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin M. Knudson more than expected).

Fields of papers citing papers by Karin M. Knudson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin M. Knudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin M. Knudson. The network helps show where Karin M. Knudson may publish in the future.

Co-authorship network of co-authors of Karin M. Knudson

This figure shows the co-authorship network connecting the top 25 collaborators of Karin M. Knudson. A scholar is included among the top collaborators of Karin M. Knudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin M. Knudson. Karin M. Knudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bross, Peter, Karin M. Knudson, Million A. Tegenge, et al.. (2025). FDA Approval Summary: Lifileucel for Unresectable or Metastatic Melanoma Previously Treated with an Anti–PD-1–Based Immunotherapy. Clinical Cancer Research. 31(19). 4004–4009. 1 indexed citations
2.
Knudson, Karin M., et al.. (2024). A Multi-Method Data Science Pipeline for Analyzing Police Service. The American Statistician. 79(1). 91–101. 1 indexed citations
3.
Pritzl, Curtis J., et al.. (2023). IKK2/NFkB signaling controls lung resident CD8+ T cell memory during influenza infection. Nature Communications. 14(1). 4331–4331. 9 indexed citations
4.
Pritzl, Curtis J., Karin M. Knudson, Vikas Saxena, et al.. (2023). STING controls T cell memory fitness during infection through T cell-intrinsic and IDO-dependent mechanisms. Proceedings of the National Academy of Sciences. 120(3). e2205049120–e2205049120. 19 indexed citations
5.
Knudson, Karin M., et al.. (2022). Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy. Frontiers in Immunology. 13. 878365–878365. 40 indexed citations
6.
Knudson, Karin M., et al.. (2022). Python for Global Applications: teaching scientific Python in context to law and diplomacy students. Proceedings of the Python in Science Conferences. 69–74.
7.
Hicks, Kristin C., Paul L. Chariou, Yohei Ozawa, et al.. (2021). Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape. Nature Communications. 12(1). 5151–5151. 58 indexed citations
8.
Gatti‐Mays, Margaret E., Sofia R. Gameiro, Yohei Ozawa, et al.. (2021). Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer. Frontiers in Oncology. 10. 581801–581801. 20 indexed citations
9.
Ozawa, Yohei, Kristin C. Hicks, Christine M. Minnar, et al.. (2021). Analysis of the tumor microenvironment and anti-tumor efficacy of subcutaneous vs systemic delivery of the bifunctional agent bintrafusp alfa. OncoImmunology. 10(1). 1915561–1915561. 5 indexed citations
10.
Hicks, Kristin C., Karin M. Knudson, Karin L. Lee, et al.. (2019). Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy. Clinical Cancer Research. 26(3). 704–716. 37 indexed citations
11.
Knudson, Karin M., Kristin C. Hicks, Sarah Alter, Jeffrey Schlom, & Sofia R. Gameiro. (2019). Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy. Journal for ImmunoTherapy of Cancer. 7(1). 82–82. 87 indexed citations
12.
Hicks, Kristin C., Karin M. Knudson, Yohei Ozawa, Jeffrey Schlom, & Sofia R. Gameiro. (2019). Evaluation of the anti-tumour efficacy and immune effects of N-809, a novel IL-15 superagonist/anti-PD-L1 bispecific agent. Annals of Oncology. 30. v500–v500. 2 indexed citations
13.
Knudson, Karin M., Kristin C. Hicks, Xiaoling Luo, et al.. (2018). M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine. OncoImmunology. 7(5). e1426519–e1426519. 168 indexed citations
14.
Hicks, Kristin C., Massimo Fantini, Renee N. Donahue, et al.. (2018). Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types. OncoImmunology. 7(11). e1466018–e1466018. 63 indexed citations
15.
Knudson, Karin M., Curtis J. Pritzl, Vikas Saxena, et al.. (2017). NFκB–Pim-1–Eomesodermin axis is critical for maintaining CD8 T-cell memory quality. Proceedings of the National Academy of Sciences. 114(9). E1659–E1667. 51 indexed citations
16.
Knudson, Karin M., Sofia R. Gameiro, Kin-Ming Lo, & Jeffrey Schlom. (2017). Abstract 594: Dual targeting of TGFb and PD-L1 promotes potent anti-tumor efficacy in multiple murine models of solid carcinomas. Cancer Research. 77(13_Supplement). 594–594. 8 indexed citations
17.
Goplen, N., Vikas Saxena, Karin M. Knudson, et al.. (2016). IL-12 Signals through the TCR To Support CD8 Innate Immune Responses. The Journal of Immunology. 197(6). 2434–2443. 29 indexed citations
18.
Malamas, Anthony S., Sofia R. Gameiro, Karin M. Knudson, & James W. Hodge. (2016). Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas’ sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation. Oncotarget. 7(52). 86937–86947. 62 indexed citations
19.
Knudson, Karin M., et al.. (2013). Low-Affinity T Cells Are Programmed to Maintain Normal Primary Responses but Are Impaired in Their Recall to Low-Affinity Ligands. Cell Reports. 4(3). 554–565. 47 indexed citations
20.
Knudson, Karin M., et al.. (2013). The POSH/JIP‐1 scaffold network regulates TCR‐mediated JNK1 signals and effector function in CD8+T cells. European Journal of Immunology. 43(12). 3361–3371. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026